Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Roche, Pfizer, GSK Close Out 2021 With Licensing Transactions

Jan 04 2022

• By Joseph Haas

Deal Watch 2021 — Alamy • Source: Shutterstock

Related Content

Viatris Pushes Back ‘Roadmap’ Reveal

Dec 20 2021

Hyloris Teams Up With Vaneltix For Value-Added Interstitial Cystitis Pain Treatment

Dec 20 2021

Keeping Track: Approvals Aplenty As FDA Clears Taltz, Cinqair And Anthim

Mar 28 2016

Keeping Track: Targeted Oncologics Tepmetko, Ukoniq Cleared; Posimir Earns Opioid-Sparing Language

Feb 06 2021

GSK Spending Spree Continues With Sosei Heptares Pact

Dec 21 2020

Major Milestone For SK Biopharm As Anti-Epileptic Gets US Approval

Nov 25 2019

Ovid Starts Neurology Spree With AstraZeneca Deal

Jan 03 2022

Biogen Re-Ups With Ionis In Search Of A Neuroscience 'Innovation Engine'

Apr 20 2018

Novartis Sneaks Ahead Of Sanofi To Buy Gyroscope

Dec 22 2021

Merck KGaA Ties Up Chord To Advance Cladribine Rare Disease Programs

Dec 21 2021

$1bn Amunix Buy Brings Sanofi Next-Generation TCE Platform

Dec 21 2021

Ipsen Gives Genfit Liver Drug New Lease Of Life

Dec 17 2021

Related Companies

Roche Holding AG

Lineage Cell Therapeutics, Inc.

Genentech, Inc.

Vera Therapeutics, Inc.

Pfizer Inc.

Amplyx Pharmaceuticals, Inc.

Novartis AG

Ligand Pharmaceuticals, Inc.

GSK plc

Icagen, Inc.

DURECT Corporation

Innocoll Holdings Limited

Scorpius Holdings, Inc.

Elusys Therapeutics, Inc.

Genfit SA

Genoscience Pharma

Biogen, Inc.

Ionis Pharmaceuticals, Inc.

Aarvik Therapeutics, Inc.

ArriVent Biopharma, Inc.

Theramex

SK Biopharmaceuticals Co., Ltd

Endo, Inc.

Helsinn Healthcare SA

Xediton Pharmaceuticals, inc.

Karyopharm Therapeutics

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window